Randomised controlled trialindependent cross-checkabstract checked I-CHM-127 standard review
Nutrition drink during chemotherapy for pancreatic cancer
Early elemental diet supplementation during chemotherapy improves treatment response and survival in advanced pancreatic cancer: A single-center randomized controlled trial.
Overview
Uemura S et al.. Clin Nutr ESPEN 2026 · PMID 41794391 · DOI 10.1016/j.clnesp.2026.103106
In a small trial, patients who took a special nutrition formula during chemotherapy lived longer (21.4 vs 12.8 months).
Does the study support the specific claim? Partly · Methodological quality: low
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Test nutritional support during chemotherapy
- How was the study done?
Small randomised trial
- How many people, animals or samples were studied?
60 patients
- What was actually found?
Better nutrition, response and survival
- How large was the observed effect?
OS HR 0.55 (0.31-0.98)
- What do the results mean in everyday life?
Good nutrition may help treatment work; it goes with treatment, not instead of it
- What are the study's limitations?
Very small, needs confirmation
- What does it say about Elawady's specific claim?
Supports nutrition alongside treatment, not instead of it
- Do the results apply to Germany and Europe?
Moderate
- What can explicitly not be concluded from this study?
Cannot show diet can replace chemotherapy
Scientific in-depth review
1. Full reference
- Authors
- Uemura S et al.
- Journal
- Clin Nutr ESPEN
- Year
- 2026
- Identifier
- PMID 41794391 DOI 10.1016/j.clnesp.2026.103106
- Verification
- verified – PubMed efetch 2026-10-26 (PublicationType and CommentsCorrections checked); Crossref 2026-10-26
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
Not stated in abstract.
2. Research question
Does an elemental diet as nutritional support during chemotherapy improve survival in advanced pancreatic cancer?
3. Study design and population
- Study design
- Randomised controlled trial – Single-centre randomised controlled trial
- Population
Patients with advanced pancreatic cancer starting chemotherapy
- Country
Japan (registry UMIN)
- Period
Not stated in abstract
- Sample size
60 randomised (30 vs 30; 3 withdrawals)
- Inclusion and exclusion criteria
Advanced pancreatic cancer on first-line chemotherapy
4. Methods and endpoints
- Exposure / intervention
Elemental diet >=1 packet/day for >=2 months plus chemotherapy
- Comparator
Normal diet plus chemotherapy
- Endpoints
OS (primary), PFS, nutritional parameters, response
- Statistical methods
HR; P values
5. Actual results
- Results
BMI decline -0.3 vs -0.6 kg/m2 (p=0.044); handgrip better preserved (p=0.010); disease control 96.3% vs 73.3% (p=0.027); response 44.4% vs 10.3% (p=0.006); PFS 9.5 vs 6.4 months (p=0.068); OS 21.4 vs 12.8 months (HR 0.55, 0.31-0.98; p=0.038).
- Absolute risks
Median OS +8.6 months
- Authors' conclusion
Early elemental diet supplementation during chemotherapy was associated with preserved nutritional status, improved response and prolonged survival.
6. Strengths
- Randomised
- Survival as primary endpoint
7. Weaknesses
- Very small single-centre trial; open-label
- Large effect from a small trial is likely to be overestimated
- Needs replication
8. Risk of bias
- Orienting tool
- RoB 2
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Small, open-label, withdrawals in one arm.
9. Assessment of the statistical interpretation
HR 0.55 (0.31-0.98) wide; lower bound near 1.
10. Relevance to the specific claim
The strongest recent randomised signal found that nutrition matters in cancer care: nutritional support given together with chemotherapy may improve outcomes. It tested diet as an addition to chemotherapy, not as a replacement.
11. Independent contrary findings
No trial found that tested a diet instead of chemotherapy or radiotherapy.
12. Transferability to Germany and Europe
Elemental diets are available in Europe; finding not yet replicated.
13. Overall methodological judgement
Preliminary evidence that nutrition support complements chemotherapy.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | low |
| Risk of bias | some concerns |
| Precision of results | low |
| Directness | indirect |
| Reproducibility | not replicated |
| Consistency with the overall evidence | unknown |
| Regional transferability | moderate |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Replication in larger trials.